NCT07509112 clinical trial report covering Semaglutide (Novo Nordisk), Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07512700 clinical trial report covering Venetoclax, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07508995 clinical trial report covering Sonrotoclax, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07511972 clinical trial report covering Pembrolizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07511725 clinical trial report covering Thiotepa, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07512674 clinical trial report covering Bevacizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07511504 clinical trial report covering Tremelimumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07512076 clinical trial report covering Enzalutamide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07511816 clinical trial report covering LY-4515100, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07511049 clinical trial report covering Brincidofovir, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07510932 clinical trial report covering Fruquintinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07511582 clinical trial report covering Methylprednisolone, Phase 2, endpoints, sponsor, geography, readout timing and development white space.